openPR Logo
Press release

Microbial Coagulants Market Opportunities, Demands and Growth Revenue by 2028 | Future Market Insights Report | DSM, Sacco System, DuPont Inc.

07-08-2019 02:14 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Future Market Insights

Microbial Coagulants Market Opportunities, Demands and Growth

Microbial Coagulants Market: Market Outlook

Microbial coagulants are derived typically from the Rhizomucor miehei, are fermentation-produced chymosin from either fungi or yeast. They are an organic, non-GMO, non-animal product and has Kosher and halal certification by recognized certifying authorities in various regions and countries. The microbial coagulants are produced by controlled fermentation of Rhizomucor miehei or pusillus, used in the food industry predominantly for cheese production.

Download sample copy of this report:
https://www.futuremarketinsights.com/reports/sample/REP-GB-8454

Microbial coagulants produce optimal taste profiles, which are comparable to traditional flavors produced using animal rennet, with the texture of long-ripened cheese. The cheese produced from microbial coagulants is also free of bitter off-notes throughout its shelf life. Microbial coagulant, presently, is produced by a limited number of manufacturers around the globe.

Microbial Coagulants Market: Dynamics

Cheese manufacturers face multiple challenges in terms of quality requirements, taste, texture, pressure to optimize whey value and sliceability. Another restrain for manufacturers is the need to produce cheese in an environment-friendly, efficient and sustainable way. Microbial coagulants offer an ideal solution in meeting these requirements.

With increasing concerns about animal welfare, microbial coagulants are preferred over calf rennet, which is derived from the stomachs of ruminants. Since increasing consumers are shifting towards a vegetarian diet, the demand for microbial coagulants is expected to increase, owing to the non-animal origin of the product.

Lack of consumer awareness and misinformation are among the key challenges in the microbial coagulants market. With limited expertise and know-how and a few manufacturers engaged in the production of microbial coagulants, the market is pegged to be in the initial phase.

Microbial Coagulants Market: Segmentation

Segmentation of the microbial coagulants starch market on the basis of form:

Dry
Liquid
Segmentation of the microbial coagulants starch market on the basis of source:

Rhizomucor Miehei
Cryphonectria Parasitica
Mucor Pusillus
Segmentation of the microbial coagulants starch market on the basis of end use:

Cheese
Ice Cream & Dessert
Yogurt
Whey
Segmentation of the microbial coagulants starch market on the basis of distribution:

Wholesale
Online retailers
Supermarkets
Specialty stores
Global Microbial Coagulants Market: Market Participants

DSM, Sacco System, DuPont Inc., Chr. Hansen, CSK Food Enrichment and Meito Sangyo Co. Ltd. are some of the key players in the global microbial coagulants market.

CONTACT:
Future Market Insights
U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Web: https://www.futuremarketinsights.com

ABOUT US:
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Microbial Coagulants Market Opportunities, Demands and Growth Revenue by 2028 | Future Market Insights Report | DSM, Sacco System, DuPont Inc. here

News-ID: 1798935 • Views:

More Releases from Future Market Insights

External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,

All 5 Releases


More Releases for Microbial

Microbial Contamination Identification Market Size Analysis by Application, Type …
According to Market Research Intellect, the global Microbial Contamination Identification market under the Aerospace and Defense category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The market for microbial contamination identification is expanding steadily due to growing concerns about product safety in industries
Major Market Shift in Microbial Identification Industry: Automated Systems Trans …
What Is the Forecasted Market Size and Growth Rate for the Microbial Identification Market? In the last few years, the size of the microbial identification market has seen significant expansion. It is projected to rise from $5.57 billion in 2024 to $6.44 billion in 2025, with a compound annual growth rate (CAGR) of 15.7%. The exponential growth during the historic period is credited to initiatives and funding from the government which
Microbial Food Ingredient Market Harvesting the Power of Microbes: The Booming M …
Microbial Food Ingredient Market Worth 4.97 Bn 2031- Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Microbial Food Ingredient Market"- By Microorganism (Bacteria, Yeast, Mold), Product Type (Starter Cultures, Protective Cultures, Probiotic Cultures), Strain (Single-Strain Culture, Multi-Strain Culture, Multi-Strain Mixed Culture) End User (Food and Beverage Manufacturers, Animal Feed Additives), Industry Trends, and Global Forecasts, 2022-2035 And
Microbial Identification Market: Unraveling Microbial Mysteries on the Path to U …
The global microbial identification market is expected to be worth US$ 3.7 billion in 2022, and to grow at a CAGR of 11.3% between 2022 and 2032, to be worth around US$ 10.7 billion by 2032. Rising demand for microbial identification products across various end-user sectors such as pharmaceutical and biotechnology, food and beverage, water and environment, diagnostic laboratories, and independent research laboratories is driving the microbial identification market. Based on
Microbial Fermentation Technology Market
According to the report, the global microbial fermentation technology market was valued at US$1,493.8 bn in 2016 and is projected to expand at a CAGR of 5.7% from 2017 to 2025, rising to a valuation of US$2,447.5 bn in 2025. Market Definition: When fungus and other microbes create secondary metabolites, microbial fermentation takes place. When the conditions are ideal, these bacteria may convert affordable nitrogen and carbon sources into crucial intermediates or
Microbial Bioreactor Market
The Global Microbial Bioreactor Market is expected to grow at a CAGR of 20.1% during the forecasting period (2022-2029). Micro bioreactors serve as a multitude of scale-down needs for bioprocesses based on mammalian cells. Microbioreactor technology has allowed for rapid advancements in biotechnology process development and investigation of various biological systems from industrial biotechnology and pharmaceutical biotechnology. Micro bioreactors range in complexity from simple micro-tier-based systems to complex automated parallel bioreactors